Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 04-2000 | 04-1999 | 04-1998 | 04-1997 | |
| Cash Flows From Operating Activities | ||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | 6,952 | 19,260 | -3,287 | -2,626 |
| Net Acquisitions | N/A | N/A | 0 | -14,623 |
| Purchase Of Investment | -123 | 0 | -323 | -202 |
| Sale Of Investment | N/A | N/A | 0 | 7,700 |
| Purchase Sale Intangibles | 27,348 | N/A | N/A | N/A |
| Other Investing Activity | 8,953 | -13,869 | -25,819 | -10,119 |
| Investing Cash Flow | $3,135 | $5,391 | $-29,429 | $-19,870 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 117 | 60 | 10,000 | 10,000 |
| Debt Repayment | -39 | -3,000 | -84 | -279 |
| Common Stock Issued | N/A | N/A | 0 | 10,289 |
| Dividend Paid | -16,155 | -13,872 | -6,872 | -19,594 |
| Other Financing Activity | 0 | 4,044 | 2,808 | -48 |
| Financing Cash Flow | $-16,077 | $-12,768 | $5,852 | $368 |
| Beginning Cash Position | 11,744 | 5,754 | 8,706 | 10,276 |
| End Cash Position | 24,729 | 11,744 | 5,754 | 8,706 |
| Net Cash Flow | $12,985 | $5,990 | $-2,952 | $-1,570 |
| Free Cash Flow | ||||
| Capital Expenditure | -17,247 | -3,682 | -3,497 | -3,022 |
| Free Cash Flow | -17,247 | -3,682 | -3,497 | -3,022 |